Compounds > fructose-1,6-diphosphate

fructose-1,6-diphosphate and cardiovascular agents

fructose-1,6-diphosphate has been researched along with cardiovascular agents in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (26.67)18.2507
2000's11 (73.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gatsura, VV; Rozonov, IuB; Sernov, LN; Shal'neva, TV; Snegireva, GV; Sokolova, OA1
Markov, AK; Olinde, KD; Rao, MR1
Chien, S; Ehringer, W; Gray, L; Niu, W; Tseng, M; Zhang, F1
Chang, Y; Li, L; Liu, J; Wang, Y1
Bogár, L; Gál, J; Riedel, BJ; Róth, E; Royston, D; Tekeres, M1
Cohly, HH; Heath, B; Markov, AK; Moore, C; Netherland, DE; Rayburn, TS; Talton, DS1
Chiang, B; Chien, S; Hua, D; Wilson, D; Ye, J; Zhuang, X1
Ellis, G; Fox, AW; Gal, J; Marangos, PJ; Riedel, BJ; Royston, D1
Chen, YQ; Huang, WB; Jin, XJ; Tang, RH; Tao, QS; Wang, BA1
Bigler, SA; Dorsett-Martin, W; Freeland, AE; Lindley, SG; Lineaweaver, W; McDaniel, O; Sud, V; Zhang, F1
Chien, S; Wheeler, TJ; Wiegand, CB1
Atluri, P; Berry, MF; Cohen, JE; Gardner, TJ; Grand, TJ; Hsu, VM; Liao, GP; Panlilio, CM; Smith, MJ; Suarez, EE; Sweeney, HL; Taylor, MD; Woo, YJ; Zentko, SE1
Cohly, HH; Markov, AK; Sauls, DJ; Skelton, TN; Warren, ET1
Acsady, G; Gal, J; Jancso, G; Kertai, MD; Riedel, B; Roth, E; Royston, D1
Bai, WX; Chen, JY; Mei, SY; Pan, WN; Pan, YY; Wang, M; Yao, J; Yu, FL1

Trials

3 trial(s) available for fructose-1,6-diphosphate and cardiovascular agents

ArticleYear
[Clinical study of fructose 1,6-diphosphate on myocardial ischemia/reperfusion injuries].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 1998, Volume: 23, Issue:5

    Topics: Cardioplegic Solutions; Cardiopulmonary Bypass; Cardiovascular Agents; Creatine Kinase; Fructosediphosphates; Heart Septal Defects, Ventricular; Humans; Isoenzymes; L-Lactate Dehydrogenase; Myocardial Reperfusion Injury

1998
Myocardial protection using fructose-1,6-diphosphate during coronary artery bypass graft surgery: a randomized, placebo-controlled clinical trial.
    Anesthesia and analgesia, 2004, Volume: 98, Issue:1

    Topics: Aged; Cardiac Output; Cardiovascular Agents; Coronary Artery Bypass; Creatine Kinase; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Fructosediphosphates; Hemodynamics; Humans; Hypothermia, Induced; Infusions, Intravenous; Isoenzymes; Male; Middle Aged; Myocardial Reperfusion Injury; Sample Size

2004
Effects of fructose-1,6-diphosphate on endo- and myocardial purine metabolism during coronary artery bypass grafting surgery.
    The Journal of cardiovascular surgery, 2007, Volume: 48, Issue:6

    Topics: Cardiovascular Agents; Coronary Artery Bypass; Double-Blind Method; Fructosediphosphates; Humans; Myocardium; Placebos; Purines; Time Factors

2007

Other Studies

12 other study(ies) available for fructose-1,6-diphosphate and cardiovascular agents

ArticleYear
[The characteristics of the cardioprotective action of fructose-1,6-diphosphate].
    Biulleten' eksperimental'noi biologii i meditsiny, 1991, Volume: 111, Issue:2

    Topics: Acidosis; Animals; Cardiovascular Agents; Coronary Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Fructosediphosphates; Male; Myocardial Infarction; Rabbits; Rats; Time Factors

1991
In vitro induction of nitric oxide by fructose-1,6-diphosphate in the cardiovascular system of rats.
    Molecular and cellular biochemistry, 1998, Volume: 185, Issue:1-2

    Topics: Animals; Cardiovascular Agents; Cardiovascular System; Carotid Arteries; Cells, Cultured; Citrulline; Dose-Response Relationship, Drug; Endothelium; Fructosediphosphates; Lymphocytes; Macrophages; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Thorax; Tritium

1998
Enhancement of hypothermic heart preservation with fructose 1, 6-diphosphate.
    The Journal of surgical research, 1999, Volume: 85, Issue:1

    Topics: Animals; Cardiovascular Agents; Cryopreservation; Fructosediphosphates; Heart; In Vitro Techniques; Lipid Bilayers; Male; Microscopy, Electron; Myocardial Reperfusion; Myocardium; Organ Preservation; Organ Size; Ovum; Oxygen Consumption; Phosphatidylcholines; Rats; Rats, Sprague-Dawley

1999
[Effect of fructose-1,6-diphosphate on myocardial purin and pyrimidin metabolism during coronary artery bypass grafting surgery].
    Orvosi hetilap, 2000, Sep-10, Volume: 141, Issue:37

    Topics: Adult; Cardiovascular Agents; Case-Control Studies; Coronary Artery Bypass; Fructosediphosphates; Humans; Immunologic Factors; Myocardium; Purines; Pyrimidines; Time Factors; Treatment Outcome

2000
Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression.
    Transplantation, 2002, Dec-15, Volume: 74, Issue:11

    Topics: Animals; Cardiovascular Agents; Cell Division; Cyclosporine; Drug Therapy, Combination; Fructosediphosphates; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interleukin-2; Rats; Rats, Inbred Lew; Rats, Inbred WF; Rats, Sprague-Dawley; T-Lymphocytes; Transplantation, Heterotopic

2002
Using fructose-1,6-diphosphate during hypothermic rabbit-heart preservation: a high-energy phosphate study.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2003, Volume: 22, Issue:5

    Topics: Animals; Cardiovascular Agents; Fructosediphosphates; Heart; Hypothermia, Induced; Myocardium; Organ Preservation Solutions; Phosphates; Rabbits; Tissue Preservation

2003
[Effect of fructose-1,6-diphosphate and dexamethasone on ischemia/reperfusion injury after hemorrhagic shock in rabbits].
    Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue, 2004, Volume: 16, Issue:1

    Topics: Animals; Cardiovascular Agents; Creatine Kinase; Dexamethasone; Disease Models, Animal; Drug Therapy, Combination; Female; Fructosediphosphates; Glucocorticoids; Heart; Male; Myocardial Reperfusion Injury; Myocardium; Rabbits; Random Allocation; Shock, Hemorrhagic; Troponin I

2004
Evaluation of fructose 1,6 diphosphate for salvage of ischemic gracilis flaps in rats.
    Journal of reconstructive microsurgery, 2005, Volume: 21, Issue:3

    Topics: Animals; Cardiovascular Agents; Fructosediphosphates; Graft Survival; Ischemia; Male; Models, Animal; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Surgical Flaps

2005
Fructose-1,6-bisphosphate enhances hypothermic preservation of cardiac myocytes.
    The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, 2005, Volume: 24, Issue:9

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Cardiovascular Agents; Cell Death; Dichloroacetic Acid; Fructosediphosphates; Glucose; Hypothermia, Induced; Insulin; Male; Myocytes, Cardiac; Preservation, Biological; Rats; Rats, Sprague-Dawley

2005
Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction.
    Heart, lung & circulation, 2006, Volume: 15, Issue:2

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Cardiovascular Agents; Fructosediphosphates; Glycolysis; Injections, Intravenous; Male; Models, Animal; Myocardial Ischemia; Myocardial Reperfusion Injury; Phosphofructokinase-1; Rats; Rats, Wistar; Ventricular Dysfunction, Left

2006
Influence of fructose-1,6-diphosphate on endotoxin-induced lung injuries in sheep.
    The Journal of surgical research, 2007, Volume: 138, Issue:1

    Topics: Animals; Cardiovascular Agents; Endotoxemia; Endotoxins; Extravascular Lung Water; Fructosediphosphates; Hypertension, Pulmonary; Leukocyte Count; Lymph; Pulmonary Wedge Pressure; Respiratory Distress Syndrome; Sheep; Vascular Resistance

2007
A subchronic intravenous toxicity study of magnesium fructose-1,6-diphosphate in beagle dogs.
    Basic & clinical pharmacology & toxicology, 2009, Volume: 104, Issue:2

    Topics: Animals; Cardiovascular Agents; Dogs; Dose-Response Relationship, Drug; Female; Fructosediphosphates; Injections, Intravenous; Lethal Dose 50; Magnesium; Male; Maximum Tolerated Dose; Toxicity Tests, Chronic

2009